News
Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...
A labeling mistake has led to a nationwide recall of four different types of Ritz peanut butter cracker sandwich cartons, ...
The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.
The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...
When the FDA unexpectedly uploaded around 200 drug rejection letters this week, the regulator provided a rare glimpse in | ...
The FDA published a database of letters sent to drugmakers during the review process of medications that provide information on the agency's initial feedback or requirements for more data. These ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
A Supreme Court jury was shown six “bricks” of a compressed plantlike material during the trial yesterday of a man charged ...
Mondelēz Global LLC recalls Ritz Peanut Butter Cracker Sandwiches due to mislabeling as cheese, posing risks for peanut allergy sufferers.
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
A powerful Senate committee has approved a bill that contains provisions hemp industry stakeholders say would devastate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results